Document Detail


Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study.
MedLine Citation:
PMID:  12011663     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To compare the effect on antihypertensive efficacy produced by the addition of indomethacin to the angiotensin II (Ang II) antagonist, valsartan, or to the angiotensin-converting enzyme inhibitor, lisinopril, in hypertensive patients with chronic osteoarthritis. SUBJECTS AND METHODS: One hundred and twenty-eight patients (52 men and 76 women) aged 25-82 years (mean age 55.7 years), with diastolic blood pressure (DBP) > 100 mmHg at the end of a 2-week placebo washout period were allocated randomly to groups to receive valsartan (80-160 mg once daily) or lisinopril (10-20 mg once daily). At the end of 10 weeks of treatment, patients with DBP < 90 mmHg, while continuing to receive valsartan or lisinopril treatment, were allocated randomly to groups to receive either indomethacin (50 mg three times a day) or the corresponding placebo for 2 weeks, with a 1-week washout period between the two treatments, according to a double-blind, crossover design. After the initial washout period, patients were examined at the end of the 4th, 8th and 10th weeks of randomized treatment with valsartan and lisinopril, at the end of the first crossover period and then at the beginning and at the end of the second crossover period. At each visit, sitting and standing blood pressure were measured by standard mercury sphygmomanometer. RESULTS: The addition of indomethacin blunted the blood pressure-decreasing effect of both antihypertensive drugs. Although indomethacin produced greater increases in both systolic and DBP values in the lisinopril-treated patients (5.45/3.22 mmHg) than in the valsartan-treated ones (2.12/1.87 mmHg), no significant difference between the two drugs was found. CONCLUSIONS: From a theoretical standpoint, these findings suggest that prostaglandins may play a part in the antihypertensive action of Ang II antagonists. From a practical standpoint, hypertensive patients treated with valsartan or with lisinopril should be monitored to detect changes in blood pressure control while receiving indomethacin.
Authors:
Roberto Fogari; Annalisa Zoppi; Renzo Carretta; F Veglio; Antonio Salvetti;
Related Documents :
2533803 - Acute effects of ethanol (0.5 mg/kg) and its interaction with diazepam (5 mg) and meclo...
2467123 - Amlodipine in hypertension: an overview of the clinical dossier.
16487853 - Rapid induction of cerebral hypothermia is enhanced with active compression-decompressi...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of hypertension     Volume:  20     ISSN:  0263-6352     ISO Abbreviation:  J. Hypertens.     Publication Date:  2002 May 
Date Detail:
Created Date:  2002-05-15     Completed Date:  2002-09-27     Revised Date:  2010-10-19    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  1007-14     Citation Subset:  IM    
Affiliation:
Dipartimento di Medicina Interna, IRCCS Policlinico S. Matteo, Università di Pavia, Pavia, Italy. r.fogari@smatteo.pv.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Angiotensin-Converting Enzyme Inhibitors / adverse effects,  therapeutic use*
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Antihypertensive Agents / adverse effects,  therapeutic use*
Chronic Disease
Drug Interactions
Female
Humans
Hypertension / complications*,  drug therapy*
Indomethacin / therapeutic use*
Lisinopril / adverse effects,  therapeutic use*
Male
Middle Aged
Osteoarthritis / complications*,  drug therapy*
Receptors, Angiotensin / antagonists & inhibitors*
Tetrazoles / adverse effects,  therapeutic use*
Treatment Outcome
Valine / adverse effects,  analogs & derivatives,  therapeutic use*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/Antihypertensive Agents; 0/Receptors, Angiotensin; 0/Tetrazoles; 137862-53-4/valsartan; 53-86-1/Indomethacin; 7004-03-7/Valine; 83915-83-7/Lisinopril
Comments/Corrections
Comment In:
J Hypertens. 2002 May;20(5):849-50   [PMID:  12011643 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Oestrogen action on the myocardium in vivo: specific and permissive for angiotensin-converting enzym...
Next Document:  Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive the...